decisionhealth Newsletters, Part B News - 2002 Issue 7 (July)
Top 10 list of most-billed drugs includes epoetin, albueterol
Subscribe or sign in to view the full article.
Article Overview
This article examines a Medicare Part B News analysis of CMS data on the most-billed drugs and the associated denial patterns reported for those services. It explains why the topic matters for coders and billing staff who work with Medicare drug claims, carrier payment practices, and CMS policy updates affecting coverage determinations for selected drug services.
Why This Topic Matters
Understanding which drugs are commonly billed and how Medicare denials vary can help coding, billing, and reimbursement professionals follow changes in carrier payment behavior and CMS policy for drug claims.
Article Sections
-
Top 10 drugs billed to Medicare in 2000
Overview of the article’s Medicare billing analysis and the summary table of frequently billed drug services. Covers general denial and payment patterns reported from CMS data.
-
Self-injectable policy a contributing factor?
Discussion of the policy background surrounding drugs that may be self-administered and how CMS and carrier guidance is presented in the article. Includes mention of a later program memo and related timing.
What You Will Learn
- How the article frames Medicare Part B drug billing trends
- What kinds of denial and payment patterns are discussed
- Why self-administered drug policy is relevant to Medicare billing
- Which CMS and carrier policy issues are referenced in the article
Who Should Read This
- Medical coders
- Billing staff
- Reimbursement analysts
- Revenue cycle professionals
- Compliance staff
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com